北京合康新能科技股份有限公司 关于为子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别风险提示： 关于为子公司提供担保的进展公告 证券代码：300048 证券简称：合康新能 编号：2025－085 北京合康新能科技股份有限公司（以下简称"公司"）提供担保总额已超过最 近一期经审计净资产 100%、对资产负债率超过 70%的单位担保金额已超过公司 最近一期经审计净资产 50%，敬请投资者注意相关担保风险。 一、担保情况概述 （一）为子公司提供担保的进展 为支持子公司业务发展需要，近日公司与兴业银行股份有限公司北京自贸试 验区高端产业片区支行（以下简称"兴业银行"）签署《最高额保证合同》，公 司为子公司北京华泰润达节能科技有限公司（以下简称"华泰润达"）与兴业银 行发生的债务提供连带责任保证，担保的债权最高额度为人民币 1 亿元。 根据《深圳证券交易所创业板股票上市规则》等相关规定，上述担保事项在 已经审议的年度担保额度范围内，无需再提交公司董事会或股东会审议。 （二）决策程序 公司于 2024 年 12 月 10 日和 2024 年 ...

格隆汇11月28日丨合康新能(300048.SZ)公布，下属子公司北京合康新能变频技术有限公司近日收到政 府补助款300万元，上述政府补助与收益相关，补助金额占公司最近一期经审计归属于上市公司股东净 利润的29.14%。上述政府补助与公司日常经营活动相关，不具有可持续性。 ...

关于公司收到政府补助的公告 证券代码：300048 证券简称：合康新能 编号：2025－084 北京合康新能科技股份有限公司 关于公司收到政府补助的公告 1、补助的类型 根据《企业会计准则第 16 号-政府补助》的规定，与资产相关的政府补助， 是指企业取得的、用于购建或以其他方式形成长期资产的政府补助；与收益相关 的政府补助，是指除与资产相关的政府补助之外的政府补助。公司本次收到的政 府补助属于与收益相关的政府补助。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、获得补助的基本情况 北京合康新能科技股份有限公司（以下简称"公司"）下属子公司北京合康新 能变频技术有限公司近日收到政府补助款 300 万元，上述政府补助与收益相关， 补助金额占公司最近一期经审计归属于上市公司股东净利润的 29.14%。上述政 府补助与公司日常经营活动相关，不具有可持续性。 二、补助的类型及其对上市公司的影响 2、补助的确认和计量 按照《企业会计准则第 16 号-政府补助》的规定，与资产相关的政府补助， 应当冲减相关资产的账面价值或确认为递延收益，在相关资产使用寿命内按照合 理 ...

Major Announcements - Glacier Network plans to sign an exclusive overseas agency agreement with Chengdu Time Race Technology Co., Ltd., a 14% owned affiliate, for the promotion and operation of "Magic War" [3] - Nairui Radar intends to acquire 100% equity of Tianjin Sigma Microelectronics Technology Co., Ltd. through a combination of share issuance and cash payment [4] - Howie Group's wholly-owned subsidiary, Shaoxing Wehao, plans to invest 200 million yuan in a private equity fund, holding an 18.39% stake [5] - Hekang New Energy's subsidiary received a government subsidy of 6 million yuan, accounting for 58.27% of the company's latest audited net profit attributable to shareholders [6] - Yanzhou Coal Mining plans to acquire 100% equity of a high-end support manufacturing company for 345 million yuan, constituting a related party transaction [7] Termination of Cooperation - Jincheng Pharmaceutical has decided to terminate its intention to cooperate with Dutch company Giskit regarding the exclusive commercialization rights of ExEm® Foam in China due to lack of substantial progress in negotiations [9] Mining License Acquisition - Hunan Gold's subsidiary Xinshao Siwei has obtained a mining license for the Xinshao County Tanxi Tungsten Mine, with an annual production capacity of 990,000 tons [10] Share Buybacks - Visionox has initiated a share buyback of 1.6607 million shares for approximately 15 million yuan, with a maximum price of 14.8 yuan per share [11] - Koli completed a share buyback amounting to 10.9949 million yuan, acquiring 845,700 shares at prices between 12.89 and 13.13 yuan per share [12] - Maide Medical's chairman proposed a share buyback plan with a total amount between 20 million and 40 million yuan [13] Shareholding Changes - Funeng Technology's shareholder plans to reduce its stake by up to 1.6816%, totaling no more than 20.551 million shares [14] - Aerospace Hongtu's director intends to sell up to 5,000 shares due to personal financial needs [15] Project Wins - Anhui Construction has won two projects with a total bid price of 2.603 billion yuan, with the company's share being approximately 600 million yuan [16][17]

Major Events - Glacier Network plans to sign an exclusive overseas agency agreement with Chengdu Time Race Technology Co., Ltd., a company in which it holds a 14% stake, for the promotion and operation of "Magic War" [4] - Nairui Radar intends to acquire 100% equity of Tianjin Sigma Microelectronics Technology Co., Ltd. through a combination of issuing shares and cash [5] - Howey Group's wholly-owned subsidiary, Shaoxing Wehao, plans to invest 200 million yuan in a private equity fund [6][7] - Hekang New Energy's subsidiary received a government subsidy of 6 million yuan, accounting for 58.27% of the company's latest audited net profit attributable to shareholders [8] - Yanzhou Coal Mining plans to acquire 100% equity of a high-end support manufacturing company for 345 million yuan, constituting a related party transaction [9] - Jincheng Pharmaceutical has decided to terminate its intention to cooperate with Dutch company Giskit regarding exclusive commercialization rights for a drug in China due to lack of substantial progress [10] - Hunan Gold's subsidiary obtained a mining license for tungsten, magnetite, and silver with an annual production capacity of 990,000 tons [11] Share Buybacks - Visionox completed its first share buyback of 1.6607 million shares for approximately 15 million yuan, with a maximum price of 14.8 yuan per share [12] - Koli completed a share buyback of 10.9949 million yuan, acquiring 845,700 shares at prices between 12.89 and 13.13 yuan per share [13][14] - Maide Medical's chairman proposed a share buyback plan with a total amount between 20 million and 40 million yuan [15] Shareholding Changes - Funeng Technology's shareholder plans to reduce its stake by up to 1.6816%, totaling approximately 20.551 million shares [16] - Aerospace Hongtu's director plans to reduce his holdings by 5,000 shares due to personal financial needs [17] Major Contracts - Anhui Construction won two projects with a total bid price of 2.603 billion yuan, with the company's share being approximately 600 million yuan for each project [18]

Group 1 - Hekang New Energy's subsidiary received a government subsidy of 6 million yuan, accounting for 58.27% of the company's latest audited net profit attributable to shareholders [1] - Anhui Construction won two major EPC projects with a total bid price of 2.603 billion yuan [2] - Tianrun Dairy's wholly-owned subsidiary received a government subsidy of 7.9094 million yuan, representing 18.12% of the company's audited net profit for 2024 [2] Group 2 - Yunnan Gold's subsidiary obtained a mining license for the Xinxiao County Tanxi Tungsten Mine, with a production capacity of 990,000 tons per year [5][22] - Yanzhou Coal Energy plans to acquire 100% equity of a high-end support company for 345 million yuan [6] - Heng Rui Pharmaceutical received approval for multiple drug clinical trials, including Sulfate Amexitin tablets [8] Group 3 - Huazhi Jie plans to invest 157 million yuan to establish five wholly-owned subsidiaries to expand its global strategy [1] - Junting Hotel's controlling shareholder is planning a change of control, leading to a continued suspension of trading [4] - Funi Technology's shareholder plans to reduce its stake by up to 1.68% [10] Group 4 - Midea Group's subsidiary received a government subsidy of 6 million yuan, which is 58.27% of the company's latest audited net profit [1] - Hunan Gold's subsidiary obtained a mining license for tungsten, iron, and silver, with a production scale of 990,000 tons per year [5][22] - Xin Hua Pharmaceutical received approval for the listing application of Acetate Prednisone raw material [24][25] Group 5 - Zhejiang Pharmaceutical plans to spin off its subsidiary for a listing on the Hong Kong Stock Exchange [28] - Kesheng Technology plans to invest 61.2 million yuan to acquire 51% of Shenzhen Guanding [30] - Tian Shan Aluminum's 1.4 million tons electrolytic aluminum green low-carbon energy efficiency improvement project has commenced production [38]

格隆汇11月27日丨合康新能(300048.SZ)公布，下属子公司安徽美的合康电力工程有限公司近日收到政 府补助款600万元，上述政府补助与收益相关，补助金额占公司最近一期经审计归属于上市公司股东净 利润的58.27%。上述政府补助与公司日常经营活动相关，不具有可持续性。 ...

关于公司收到政府补助的公告 一、获得补助的基本情况 北京合康新能科技股份有限公司 关于公司收到政府补助的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：300048 证券简称：合康新能 编号：2025－083 关于公司收到政府补助的公告 公司本次收到的上述政府补助与公司日常活动相关，属于与企业日常经营活 动相关的政府补助，计入其他收益，金额为 600 万元。预计将增加公司 2025 年 度利润总额 480 万元。 二、补助的类型及其对上市公司的影响 1、补助的类型 根据《企业会计准则第 16 号-政府补助》的规定，与资产相关的政府补助， 是指企业取得的、用于购建或以其他方式形成长期资产的政府补助；与收益相关 的政府补助，是指除与资产相关的政府补助之外的政府补助。公司本次收到的政 府补助属于与收益相关的政府补助。 2、补助的确认和计量 按照《企业会计准则第 16 号-政府补助》的规定，与资产相关的政府补助， 应当冲减相关资产的账面价值或确认为递延收益，在相关资产使用寿命内按照合 理、系统的方法分期计入损益。与收益相关的政府补助，用于补偿企业以后期 ...

人民财讯11月27日电，合康新能（300048）11月27日公告，下属子公司安徽美的合康电力工程有限公司 近日收到政府补助款600万元，上述政府补助与收益相关，补助金额占公司最近一期经审计归属于上市 公司股东净利润的58.27%。 ...

关于 2020 年限制性股票激励计划预留授予部分第四个归属期归属结果暨股票上市的公告 证券代码：300048 证券简称：合康新能 编号：2025－082 北京合康新能科技股份有限公司 关于 2020 年限制性股票激励计划预留授予部分 第四个归属期归属结果暨股票上市的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 1、本次归属的激励对象人数：8 人； 2、本次归属的第二类限制性股票数量：537,500 股，占目前公司总股本的 0.0477%。 3、本次归属的股票来源：公司向激励对象定向发行公司 A 股普通股股票。 4、本次归属的股票上市流通日期：2025 年 11 月 24 日。 北京合康新能科技股份有限公司（以下简称"公司"）于 2025 年 10 月 23 日召开第六届董事会第二十四次会议和第六届监事会第二十二次会议审议通过 了《关于 2020 年限制性股票激励计划预留授予部分第四个归属期符合归属条件 的议案》，近日公司完成了 2020 年限制性股票激励计划（以下简称"本激励计划"） 预留授予部分第四个归属期归属股票的登记。现将相关事项 ...